What's Going On With G1 Therapeutics Stock?

Zinger Key Points
  • According to a report from Seeking Alpha, G1 Therapeutics has received and rejected multiple offers from TerSera Therapeutics.
  • One offer from TerSera is rumored to have a contingent value right which could value the company at between $12 and $14 per share.

G1 Therapeutics, Inc. GTHX shares are trading higher Thursday amid M&A blog speculation of a takeover offer. 

What To Know:

According to a report from Seeking Alpha, G1 Therapeutics has received and rejected multiple offers from TerSera Therapeutics.  According to the report, one offer from TerSera is rumored to have a contingent value right which could value the company at between $12 and $14 per share.

G1 Therapeutics shares are climbing on heavy trading volume as investors digest the rumors of a possible takeover offer. According to data from Benzinga Pro, more than 25.4 million shares have already been traded in the session, compared to the stock’s 100-day average of 1.136 million shares.

Needham analyst Gil Blum has a Buy rating and $12 price target on G1 Therapeutics, and HC Wainwright & Co. recently maintained its Buy rating and $9 price target on the stock.

Related News: What's Going On With Affirm Stock After Earnings? 

GTHX Stock Prediction 2024:

Equity research can be a valuable source of information for learning about a company's fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.

Shares of G1 Therapeutics have an average 1-year price target of $10.17, representing an expected upside of 75.65%.

Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. No analysts have bearish recommendations on G1 Therapeutics, while 6 analysts have bullish ratings. The street high price target from Needham is $12, while the street low from Wedbush is $4.

GTHX Price Action: According to Benzinga Pro, G1 Therapeutics shares are up 17.85% at $5.06 at the time of publication Thursday.

Image: james-yarema from Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsRumorsMoverswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!